|
1
|
Hoeben A, Polak J, Van De Voorde L,
Hoebers F, Grabsch HI and de Vos-Geelen J: Cervical esophageal
cancer: A gap in cancer knowledge. Ann Oncol. 27:1664–1674. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buda A, Elisei F, Palazzi S, De Ponti E,
Arosio M, Vecchione F, Dell'Anna T, Cuzzocrea M, Bussi B, Giuliani
D, et al: Quality of care for cervical and endometrial cancer
patients: The impact of different techniques of sentinel lymph node
mapping on patient satisfaction. Ann Surg Oncol. 23:2975–2981.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meier T and Kharofa J: Magnetic resonance
imaging-guided high-dose rate brachytherapy for cervical cancer.
Semin Roentgenol. 51:106–111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang XI, Luo Y, Zhao S, Chen Q, Jiang C,
Dai Y, Chen Y and Cao Z: Clinical significance and expression of
microRNA in diabetic patients with erectile dysfunction. Exp Ther
Med. 10:213–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jia W, Wu Y, Zhang Q, Gao GE, Zhang C and
Xiang Y: Expression profile of circulating microRNAs as a promising
fingerprint for cervical cancer diagnosis and monitoring. Mol Clin
Oncol. 3:851–858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Graziano A, Lo Monte G, Piva I, Caserta D,
Karner M, Engl B and Marci R: Diagnostic findings in adenomyosis: A
pictorial review on the major concerns. Eur Rev Med Pharmacol Sci.
19:1146–1154. 2015.PubMed/NCBI
|
|
7
|
Zhang Z, Wang J, Wang X, Song W, Shi Y and
Zhang L: MicroRNA-21 promotes proliferation, migration, and
invasion of cervical cancer through targeting TIMP3. Arch Gynecol
Obstet. 297:433–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang SF, Liu YF, Cheng CW, Yang WE, Lin
WL, Ko JL and Wang PH: Impact of microRNA-34a and polymorphism of
its target gene CA9 on susceptibility to uterine cervical cancer.
Oncotarget. 8:77860–77871. 2017.PubMed/NCBI
|
|
9
|
Zhou X, Yue Y, Wang R, Gong B and Duan Z:
MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer
stem cells. Int J Oncol. 50:853–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang Z, Song Q, Zeng R, Li J, Li J, Lin
X, Chen X, Zhang J and Zheng Y: MicroRNA-218 inhibits EMT,
migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical
cancer. Oncotarget. 7:45622–45636. 2016.PubMed/NCBI
|
|
11
|
Xu L, Xu Q, Li X and Zhang X: MicroRNA-21
regulates the proliferation and apoptosis of cervical cancer cells
via tumor necrosis factor-α. Mol Med Rep. 16:4659–4663. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen B, Chen X, Wu X, Wang X, Wang Y, Lin
TY, Kurata J, Wu J, Vonderfecht S, Sun G, et al: Disruption of
microRNA-21 by TALEN leads to diminished cell transformation and
increased expression of cell-environment interaction genes. Cancer
Lett. 356:506–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wen Q, Liu Y, Lyu H, Xu X, Wu Q, Liu N,
Yin Q, Li J and Sheng X: Long noncoding RNA GAS5, which acts as a
tumor suppressor via microRNA 21, regulates cisplatin resistance
expression in cervical cancer. Int J Gynecol Cancer. 27:1096–1108.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi J: Considering exosomal miR-21 as a
biomarker for cancer. J Clin Med. 5(pii): E422016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Zhan X, Yan D and Wang Z:
Circulating MicroRNA-21 is involved in lymph node metastasis in
cervical cancer by targeting RASA1. Int J Gynecol Cancer.
26:810–816. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Sun H, Wang X, Yu Q, Li S, Yu X and
Gong W: Increased exosomal microRNA-21 and microRNA-146a levels in
the cervicovaginal lavage specimens of patients with cervical
cancer. Int J Mol Sci. 15:758–773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gocze K, Gombos K, Juhasz K, Kovacs K,
Kajtar B, Benczik M, Gocze P, Patczai B, Arany I and Ember I:
Unique microRNA expression profiles in cervical cancer. Anticancer
Res. 33:2561–2567. 2013.PubMed/NCBI
|
|
18
|
Yao Q, Xu H, Zhang QQ, Zhou H and Qu LH:
MicroRNA-21 promotes cell proliferation and down-regulates the
expression of programmed cell death 4 (PDCD4) in HeLa cervical
carcinoma cells. Biochem Biophys Res Commun. 388:539–542. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiu C, Hou G and Huang D: Molecular
mechanism of TNF-α signal transduction. Chin J Biochemistry Mol
Biol. 23:430–435. 2007.
|
|
20
|
Micheau O and Tschopp J: Induction of TNF
receptor I-mediated apoptosis via two sequential signaling
complexes. Cell. 114:181–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y and Wang JK: The functional
analysis of MicroRNAs involved in NF-kappaB signaling. Eur Rev Med
Pharmacol Sci. 20:1764–1774. 2016.PubMed/NCBI
|
|
22
|
Gao Q, Xu L, Yang Q and Guan TJ:
MicroRNA-21 contributes to high glucose-induced fibrosis in
peritoneal mesothelial cells in rat models by activation of the
Ras-MAPK signaling pathway via Sprouty-1. J Cell Physiol. Dec
4–2018.(Epub ahead of print).
|
|
23
|
Zhang H, Wang Y, Lv Q, Gao J, Hu L and He
Z: MicroRNA-21 overexpression promotes the neuroprotective efficacy
of mesenchymal stem cells for treatment of intracerebral
hemorrhage. Front Neurol. 9:9312018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Z, Chen Q, Zhang J, Wang Y, Hu X,
Yin S, He M, Guan S, Qin W, Xiao Q, et al: Associations of genetic
polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer
risk: A meta-analysis in Asian population. Sci Rep. 7:178442017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu SL, Chang AC, Huang CC, Tsai CH, Lin CC
and Tang CH: Myostatin promotes interleukin-1β expression in
rheumatoid arthritis synovial fibroblasts through inhibition of
miR-21-5p. Front Immunol. 8:17472017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suzuki C, Garces RG, Edmonds KA, Hiller S,
Hyberts SG, Marintchev A and Wagner G: PDCD4 inhibits translation
initiation by binding to eIF4A using both its MA3 domains. Proc
Natl Acad Sci USA. 105:3274–3279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gong B, Liu WW, Nie WJ, Li DF, Xie ZJ, Liu
C, Liu YH, Mei P and Li ZJ: MiR-21/RASA1 axis affects malignancy of
colon cancer cells via RAS pathways. World J Gastroenterol.
21:1488–1497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tidyman WE and Rauen KA: The RASopathies:
Developmental syndromes of Ras/MAPK pathway dysregulation. Curr
Opin Genet Dev. 19:230–236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mourtada-Maarabouni M and Williams GT:
Growth arrest on inhibition of nonsense-mediated decay is mediated
by noncoding RNA GAS5. Biomed Res Int. 2013:3580152013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martin del Campo SE, Latchana N, Levine
KM, Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI,
Carson M, Ganju A, et al: MiR-21 enhances melanoma invasiveness via
inhibition of tissue inhibitor of metalloproteinases 3 expression:
In vivo effects of MiR-21 inhibitor. PLoS One. 10:e01159192015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu
S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M,
Yamaguchi K and Hashimoto H: Association of microRNA-21 expression
with its targets, PDCD4 and TIMP3, in pancreatic ductal
adenocarcinoma. Mod Pathol. 25:112–121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cai L, Wang W, Li X, Dong T, Zhang Q, Zhu
B, Zhao H and Wu S: MicroRNA-21-5p induces the metastatic phenotype
of human cervical carcinoma cells in vitro by targeting the von
Hippel-Lindau tumor suppressor. Oncol Lett. 15:5213–5219.
2018.PubMed/NCBI
|
